Proposed Information Collection Activity; Comment Request, 17421-17422 [2011-7157]
Download as PDF
<![CDATA[
17421
Federal Register / Vol. 76, No. 60 / Tuesday, March 29, 2011 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average burden
per response
(in hours)
Total burden
hours
Respondents
Form
Prison official in DOC ...........
NSPH Questionnaire ............
17
1
4
68
Total ...............................
...............................................
..............................
..............................
..............................
68
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2011–7300 Filed 3–28–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number NIOSH–227]
Request for Information on Conditions
Relating to Cancer To Consider for the
World Trade Center Health Program
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice and extension of public
comment period.
AGENCY:
On March 8, 2011, the
Director of the National Institute of
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC) published
a notice in the Federal Register (76 FR
12740) requesting information from the
public on three questions regarding
conditions relating to cancer for
consideration under the World Trade
Center Health Program. Written
comment was to be received by March
31, 2011. NIOSH has received comment
about extending the request for
information to include persons living
and working in the affected area. In
consideration of that comment, the
Director of NIOSH is modifying one of
the questions posed in the Federal
Register and extending the public
comment period to April 29, 2011.
DATES: Written or electronic comments
must be received on or before April 29,
2011. Please refer to SUPPLEMENTARY
INFORMATION for additional information.
ADDRESSES: You may submit comments,
identified by docket number NIOSH–
227, by any of the following methods:
• Mail: NIOSH Docket Office, Robert
A. Taft Laboratories, MS–C34, 4676
jlentini on DSKJ8SOYB1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:37 Mar 28, 2011
Jkt 223001
Columbia Parkway, Cincinnati, OH
45226.
• Facsimile: (513) 533–8285.
• E-mail: nioshdocket@cdc.gov.
All information received in response to
this notice will be available for public
examination and copying at the NIOSH
Docket Office, 4676 Columbia Parkway,
Cincinnati, Ohio 45226. The comment
period for NIOSH–227 will close on
April 29, 2011. All comments received
will be available on the NIOSH Docket
Web page at https://www.cdc.gov/niosh/
docket, and comments will be available
in writing by request. NIOSH includes
all comments received without change
in the docket and the electronic docket,
including any personal information
provided.
FOR FURTHER INFORMATION CONTACT: Dori
Reissman, M.D., NIOSH, Patriots Plaza
Suite 9200, 395 E. St., SW., Washington,
DC 20201, telephone (202) 245–0625 or
e-mail nioshdocket@cdc.gov.
SUPPLEMENTARY INFORMATION: The
Director of the National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC) serves as
the World Trade Center (WTC) Program
Administrator for certain functions
related to the WTC Health Program
established by the James Zadroga 9/11
Health and Compensation Act (Pub. L.
111–347). In accordance with Section
3312(a)(5)(A) of that Act, the WTC
Program Administrator is conducting a
review of all available scientific and
medical evidence to determine if, based
on the scientific evidence, cancer or a
certain type of cancer should be added
to the applicable list of health
conditions covered by the World Trade
Center Health Program.
The WTC Program Administrator is
requesting information on the following:
(1) Relevant reports, publications, and
case information of scientific and
medical findings where exposure to
airborne toxins, any other hazard, or any
other adverse condition resulting from
the September 11, 2001 terrorist attacks,
is substantially likely to be a significant
factor in aggravating, contributing to, or
causing cancer or a type of cancer; (2)
clinical findings from the Clinical
Centers of Excellence providing
monitoring and treatment services to
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
WTC responders (i.e., those persons
who performed rescue, recovery, cleanup and remediation work on the WTC
disaster sites) and community members
directly exposed to the dust cloud, gases
and vapors on 9/11/01 and those living
and working in the affected area; and (3)
input on the scientific criteria to be used
by experts to evaluate the weight of the
medical and scientific evidence
regarding such potential health
conditions.
Dated: March 22, 2011.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2011–7299 Filed 3–28–11; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[OMB No. 0980–0162]
Proposed Information Collection
Activity; Comment Request
Proposed Projects/Title: State
Developmental Disabilities Council 5Year State Plan.
Description
A Plan developed by the State
Council on Developmental Disabilities
is required by Federal statute. Each
State Council on Developmental
Disabilities must develop the plan,
provide for public comments in the
State, provide for approval by the State’s
Governor, and finally submit the plan
on a five-year basis. On an annual basis,
the Council must review the plan and
make any amendments. The State Plan
will be used (1) by the Council as a
planning document; (2) by the citizenry
of the State as a mechanism for
commenting on the plans of the
Council; and (3) by the Department as
a stewardship tool, for ensuring
compliance with the Developmental
Disabilities Assistance and Bill of Rights
Act, as one basis for providing technical
assistance (e.g., during site visits), and
E:\FR\FM\29MRN1.SGM
29MRN1
17422
Federal Register / Vol. 76, No. 60 / Tuesday, March 29, 2011 / Notices
as a support for management decision
making.
Respondents: 55 State Developmental
Disabilities Councils.
ANNUAL BURDEN ESTIMATES
Plan ..................................................................................................
Estimated Total Annual Burden
Hours:
In compliance with the requirements
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. E-mail address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2011–7157 Filed 3–28–11; 8:45 am]
jlentini on DSKJ8SOYB1PROD with NOTICES
BILLING CODE 4184–01–P
VerDate Mar<15>2010
16:37 Mar 28, 2011
Jkt 223001
Number of responses per respondent
Number of respondents
Instrument
55
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0002]
Orthopaedic and Rehabilitation
Devices Panel of the Medical Devices
Advisory Committee; Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committee: Orthopaedic and
Rehabilitation Devices Panel of the
Medical Devices Advisory Committee.
General Function of the Committee:
To provide advice and
recommendations to the Agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on May 12, 2011, from 8 a.m. to 6
p.m.
Location: Hilton, Washington DC
North/Gaithersburg, Salons A, B, C, and
D, 620 Perry Pkwy., Gaithersburg, MD
20877.
Contact Person: Margaret McCabeJanicki, Food and Drug Administration,
Center for Devices and Radiological
Health, 10903 New Hampshire Ave.,
Bldg. 66, rm. 1535, Silver Spring, MD
20993–0002, 301–796–7029, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area), and follow the
prompts to the desired center or product
area. Please call the Information Line for
up-to-date information on this meeting.
A notice in the Federal Register about
last minute modifications that impact a
previously announced advisory
committee meeting cannot always be
published quickly enough to provide
timely notice. Therefore, you should
always check the Agency’s Web site and
call the appropriate advisory committee
hot line/phone line to learn about
possible modifications before coming to
the meeting.
Agenda: On May 12, 2011, the
committee will discuss, make
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Average burden
hours per response
1
367
Total burden
hours
20,185
recommendations, and vote on
information related to the premarket
approval application (PMA) for the
Augment Bone Graft, sponsored by
Biomimetic Therapeutics, Inc. The
intended use of the device is as an
alternative bone grafting substitute to
autologous bone graft in applications to
facilitate fusion in the ankle and foot
without necessitating an additional
invasive procedure to harvest the graft.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before May 5, 2011. Oral
presentations from the public will be
scheduled between approximately 1
p.m. and 2 p.m. Those individuals
interested in making formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before April 25,
2011. Time allotted for each
presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by April 28, 2011.
Persons attending FDA’s advisory
committee meetings are advised that the
E:\FR\FM\29MRN1.SGM
29MRN1
]]>Agencies
[Federal Register Volume 76, Number 60 (Tuesday, March 29, 2011)]
[Notices]
[Pages 17421-17422]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-7157]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
[OMB No. 0980-0162]
Proposed Information Collection Activity; Comment Request
Proposed Projects/Title: State Developmental Disabilities Council
5-Year State Plan.
Description
A Plan developed by the State Council on Developmental Disabilities
is required by Federal statute. Each State Council on Developmental
Disabilities must develop the plan, provide for public comments in the
State, provide for approval by the State's Governor, and finally submit
the plan on a five-year basis. On an annual basis, the Council must
review the plan and make any amendments. The State Plan will be used
(1) by the Council as a planning document; (2) by the citizenry of the
State as a mechanism for commenting on the plans of the Council; and
(3) by the Department as a stewardship tool, for ensuring compliance
with the Developmental Disabilities Assistance and Bill of Rights Act,
as one basis for providing technical assistance (e.g., during site
visits), and
[[Page 17422]]
as a support for management decision making.
Respondents: 55 State Developmental Disabilities Councils.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Instrument Number of responses per hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
Plan.................................... 55 1 367 20,185
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours:
In compliance with the requirements of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Administration for Children and
Families is soliciting public comment on the specific aspects of the
information collection described above. Copies of the proposed
collection of information can be obtained and comments may be forwarded
by writing to the Administration for Children and Families, Office of
Administration, Office of Information Services, 370 L'Enfant Promenade,
SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. E-mail
address: infocollection@acf.hhs.gov. All requests should be identified
by the title of the information collection.
The Department specifically requests comments on: (a) Whether the
proposed collection of information is necessary for the proper
performance of the functions of the agency, including whether the
information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) the quality, utility, and clarity of the information
to be collected; and (d) ways to minimize the burden of the collection
of information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted
within 60 days of this publication.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2011-7157 Filed 3-28-11; 8:45 am]
BILLING CODE 4184-01-P
